Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Biomarker | group | GENOMICS_ENGLAND | De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome. | 30827498 | 2019 | ||||
|
0.100 | GeneticVariation | group | CLINVAR | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO | |||||||
|
0.100 | Biomarker | group | HPO |